Evommune, Inc. (EVMN)
NYSE · Manufacturing · Pharmaceutical preparations
$8.49−$0.3100 (−3.52%) on the dayAs of the close; data may be delayed.
EVMN price, last 12 months
Key stats
- Previous close
- $8.80
- Open
- $8.78
- Day range
- $8.33 – $8.78
- 52-week range
- $8.25 – $33.20
- Volume
- 542.1K
- Avg volume (20 days)
- 782.1K
- Market cap
- $308.1M
Performance
1W−12.0%
1M−39.8%
3M−66.3%
6M−64.1%
YTD−50.4%
1Y—
Technicals and fundamentals
About Evommune, Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE
- Market cap
- $308.1M